Steve Brozak Quotations

If they had been serious, they would have gone close to -- or back to -- their original offer.

I lost track of the number of times in its conference call (on Tuesday) J&J said how important medical devices were to the company. That means to me every single medical device company out there should wonder if they are going to get a knock on their door from them in the near future.

Given their financial acumen, they are pretty much self-sustaining for the foreseeable future. They've managed that by tapping into the capital markets. These folks have learned very well; they don't want to be caught at the mercy of anybody.

We've entered into the surreal as far as I'm concerned with the manner that this has been reached so far. Whether or not it's worth it is a question mark.

Guidant was in a position that was one in which they had to go through with this merger.

Guidant was in a position ... in which they had to go through with this merger.

Guidant should be very appreciative of the fact that Boston Scientific has help raise shareholder value (for them).

J&J tried to go out there and save face (on Wednesday) and not return to its original offer. They tried to argue that a bird in the hand was worth more than two in the bush -- that the certainty of closing was worth something.

Our military is being stretched too thin, to the point of being broken for the foreseeable future. We are asking too much and not giving enough, and we are certainly not any safer than before September 11.

Merck would have been in a desperate situation if it had not won this case because a negative verdict would have encouraged waves of other plaintiffs to come forward.

The fact that they've waited this long leads me to believe they will put a higher offer on the table.

When you make assumptions about a drug at this initial stage they are assumptions that can only be validated years down the road.

What are they thinking about now? The fact that J&J is silent on that speaks volumes about what they had attempted to do before -- just to get a good price.

Boston Scientific will not go quietly into the night.

The silence was really deafening, given that everybody cares about one thing Guidant. Above all, the future of J&J is dictated by what happens with Guidant.

The silence was really deafening, given that everybody cares about one thing - Guidant. Above all, the future of J&J is dictated by what happens with Guidant.

The thing that comes to mind is that Guidant blinked (in the negotiations).

The thing that comes to mind is that Guidant blinked.

I don't see how this can end well. I think the perception is that the deal will collapse and it will be full legal employment for both sides. I cannot see how they can avoid this all ending up in court.

I don't see how (J&J) can come back at this point.